Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FVXY4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,633
Award facts
- Contract value 100% obligated
- $1,632.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors on October 14, 2025, with an ultimate completion date of October 15, 2025. The contract is valued at $1,632.54 and utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices. This particular delivery order for Mounjaro, a diabetes medication, reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through the DLA's Pharmaceutical Prime Vendor program, which is designed to enable flexible and comprehensive pharmaceutical support to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FVXY4?
SPE2DB26FVXY4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FVXY4 worth?
The government has obligated $1,633 on SPE2DB26FVXY4.
Is contract SPE2DB26FVXY4 an order under another contract?
Yes. SPE2DB26FVXY4 is a delivery order under SPE2DB24D1034, an indefinite delivery contract.
Was contract SPE2DB26FVXY4 competed?
The extent of competition for SPE2DB26FVXY4 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award